(Q41500719)

1 October 2017

1 reference

title

Wild-type p53 gene transfer: a novel therapeutic strategy for neointimal hyperplasia after arterial injury (English)

1 reference

1 October 2017

Yonemitsu Y

1

1 reference

1 October 2017

Kaneda Y

2

1 reference

1 October 2017

Hata Y

3

1 reference

1 October 2017

Nakashima Y

4

1 reference

1 October 2017

Sueishi K

5

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Annals of the New York Academy of Sciences

1 October 2017

1 reference

1 October 2017

811

1 reference

1 October 2017

395-400

1 reference

WAF1, a potential mediator of p53 tumor suppression

1 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB52019.X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB52019.X

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB52019.X

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB52019.X

The effects of low-dose radiation on neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB52019.X

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB52019.X

10.1111/J.1749-6632.1997.TB52019.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference